Health Care Services
DaVita HealthCare Partners Inc (DVA)
BUY. 12-month probability-weighted target $212 (+18% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.
CVS Health Corp (CVS)
BUY. 12-month probability-weighted target $102 (+18% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.
Cigna Corp (CI)
HOLD. 12-month probability-weighted target $269 (-5% vs spot). Gross Margin explains 67% of Monte Carlo outcome variance.
Chemed Corp (CHE)
HOLD. 12-month probability-weighted target $502 (+1% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.
Sotera Health Co (SHC)
HOLD. 12-month probability-weighted target $17 (-3% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.
Laboratory Corporation of America Holdings (LH)
SELL. 12-month probability-weighted target $277 (-11% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.
Quest Diagnostics Incorporated (DGX)
SELL. 12-month probability-weighted target $201 (-13% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.
Hims Hers Health Inc (HIMS)
Rating suspended since 2026-09-29 — valuation input under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.
BrightSpring Health Services, Inc. Common Stock (BTSG)
Rating suspended since 2026-09-29 — valuation method under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.